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Background
Incorporation of fish oil (FO) into the diet of rodents has
been shown to result in positive changes in bone health.
Currently it is poorly understood if FO has the same
effects on bone health in humans. The purpose of this
study was to determine the effects of supplemental FO
on levels of urinary N-terminal cross-linked telopeptide
(NTx), which is a marker of bone breakdown, and how
this is related to the morning levels of salivary cortisol
and urinary excretion of interleukin 6 (IL-6).
Methods
A total of twenty-eight females and twelve males(35 ±
13yrs; 69.1 ± 14.1kg; 29.4 ± 9.2% body fat; mean ± SD)
participated in this study. All testing was conducted in
the morning following an overnight fast. Baseline mea-
surements of salivary cortisol were collected via passive
drool and baseline measurements of urinary NTxand IL-
6 were collected from the second void of the day and
corrected for creatinine excretion. After baseline testing,
subjects were assigned randomly in a double blind man-
ner to one of two groups: 4 g/d of Safflower Oil (SO) or
4 g/d of FO supplying 1,600 mg/d eicosapentaenoic acid
(EPA) and 800 mg/d docosahexaenoic acid (DHA). All
tests were repeated following 6wk of treatment. A treat-
ment by time, repeated measures ANOVA was used to
evaluate differences between groups over time, and a
standard Pearson’s r was used to evaluate correlations.
Additionally, within group pre-post differences were
evaluated using a repeated measures t-test. For all analy-
sis, the alpha level was set at p<0.05.
Results
Compared to the SO group, there was a significant
decrease in urinary creatinine corrected NTx excretion
following FO treatment (SO = 17.5 ± 42.9 BCE/mM;
FO = -11.3 ± 27.7 BCE/mM; p=0.02). There was also a
tendency for urinary creatinine corrected IL-6 excretion
(SO = -0.08 ± 1.18pg/mg; FO = -1.8 ± 3.8 pg/mg;
p=0.08), and salivary cortisol (SO = 0.029±0.283 µg/dL;
FO = -0.069 ± 0.144 µg/dL; p=0.13) to decrease follow-
ing FO treatment.When analyzed independently, how-
ever, there was a significant pre-post reduction for
salivary cortisol in the FO group (p=0.04), with no
change in the SO group (p=0.68), as well as a significant
reduction pre-post for urinary IL-6 in the FO group
(p=0.05), with no change in the SO group (p=0.78).
However, the change in urinary NTx concentrationwas
not related to the change insalivary cortisol concentra-
tion(r=-0.017, p=0.9), or the change in urinary IL-6 con-
centration (r=-0.323, p=0.26).
Conclusions
Six weeks of supplementation with FO in adults signifi-
cantly decreased urinary NTx excretion, but this change
was not related to changes in cortisol or IL-6.
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